StageIncubator/Accelerator | Alive
About Encore Path
Encore Path, Inc. will sell proprietary neural regenerative stroke rehabilitation devices. The Company's first product is a patented arm training device which has been shown to unmask neural pathways in the brain, leading to restoration of arm movement in patients who have moderate arm paralysis. Encore Path will develop a suite of evidence-based stroke rehabilitation devices based on the latest neurological research to improve the quality of life for over 5.5 million stroke survivors.
Missing: Encore Path's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Encore Path's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest Encore Path News
Oct 24, 2011
Encore Path Joins Astia’s Global Network of entrepreneurs, investors, corporations and industry leaders. With Astia's network, Encore Path is poised to accelerate its global growth. Baltimore, MD (PRWEB) October 24, 2011 Encore Path, makers of the revolutionary Tailwind device for arm rehabilitation for stroke and brain injury survivors – http://www.tailwindtherapy.com–today announced its invitation to join Astia, the premier global network serving women-led high growth s
Encore Path Frequently Asked Questions (FAQ)
Where is Encore Path's headquarters?
Encore Path's headquarters is located at 2400 Boston Street, Baltimore.
What is Encore Path's latest funding round?
Encore Path's latest funding round is Incubator/Accelerator.
Who are the investors of Encore Path?
Investors of Encore Path include Emerging Technology Center.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.